Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

520.80INR
12 Dec 2017
Change (% chg)

Rs-7.70 (-1.46%)
Prev Close
Rs528.50
Open
Rs531.00
Day's High
Rs533.70
Day's Low
Rs519.50
Volume
189,291
Avg. Vol
489,709
52-wk High
Rs728.45
52-wk Low
Rs433.15

Latest Key Developments (Source: Significant Developments)

Sun Pharma Industries MD says no new updates on Halol; awaiting FDA re-inspection of plants‍​
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Sun Pharmaceutical Industries managing director Dilip Shanghvi says::No new updates on halol, awaiting FDA reinspection of plants‍​.  Full Article

Sun Pharma Industries says co expects performance to improve in H2 FY17-18
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::Says challenging U.S. pricing environment, investments in building global specialty business hit Q2 performance‍​.Says co expects performance to gradually improve in second half of the year.  Full Article

India's Sun Pharmaceutical Industries Sept-qtr consol profit falls 59 pct
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::Sept quarter consol net profit 9.12 billion rupees versus profit of 22.35 billion rupees last year.Consensus forecast for Sept quarter consol profit was 8.27 billion rupees.Sept quarter consol total revenue from operations 66.50 billion rupees versus 82.60 billion rupees last year.  Full Article

Beijing Science Sun Pharmaceutical announces change in accounting policy
Thursday, 26 Oct 2017 

Oct 26(Reuters) - Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ>:Says it changes accounting policy based on accounting standards for business enterprises No. 16—government subsidies, which was disclosed by the Ministry of Finance on May 10, effective June 12.  Full Article

Sun Pharmaceutical Industries gets U.S.FDA nod for generic Coreg CR‍​
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Sun Pharmaceutical Industries Ltd ::Says gets U.S.FDA nod for generic Coreg CR‍​.  Full Article

Beijing Science Sun Pharmaceutical sees Q1~Q3 FY 2017 net profit down 15 pct to up 15 pct
Saturday, 14 Oct 2017 

Oct 14(Reuters) - Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ> : :Sees Q1~Q3 FY 2017 net profit to decrease by 15 percent to increase by 15 percent, or to be 171.2 million yuan to 231.7 million yuan.Says Q1~Q3 FY 2016 net profit was 201.5 million yuan.The reasons for the forecast are steady operation performance and aggressive market promotion .  Full Article

Sun Pharmaceutical Industries says unit raises shareholding in Ranbaxy Malaysia Sdn Bhd
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - Sun Pharmaceutical Industries Ltd :Unit agreed to increase shareholding in Ranbaxy Malaysia Sdn Bhd via purchase of 666,985 shares of Ranbaxy Malaysia.  Full Article

Sun Pharma Industries says U.S. FDA inspection closed at co's Dadra facility‍​
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Sun Pharmaceutical Industries Ltd :Says U.S. FDA inspection at co's Dadra facility‍​ is closed.  Full Article

Sun Pharma, NIV in pact to test biologic, chemical entities against zika,chikungunya, dengue
Tuesday, 27 Jun 2017 

June 27 (Reuters) - Sun Pharmaceutical Industries Ltd ::Sun Pharma & NIV sign agreement to fight zika, chikungunya and dengue.Signed agreement for testing phytopharmaceutical, biologic, chemical entities developed by co against zika, chikungunya, dengue viruses.Sun Pharma will provide drug molecules to NIV for testing against zika, chikungunya and dengue in model systems.Candidate molecules with encouraging data will then be taken forward for commercial development.Patients are given symptomatic treatment.  Full Article

Sun Pharmaceutical Industries exec says co expects to be able to address Halol issues over next few qtrs
Tuesday, 14 Feb 2017 

Sun Pharmaceutical Industries Ltd : Exec says expects to be able to address Halol issues over the next few quarters . Exec says continues to update FDA on remediation progress at Halol plant . Exec says to focus on improving supply and improving market share in United States . Exec says base business continues to have challenges related to pricing Further company coverage: [SUN.NS] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

TABLE-India Commercial Papers deals on F-TRAC-Dec 11

Dec 11 Following are the details of deals in Indian Commercial Papers reported on Clearcorp F-TRAC Platform. ISIN DESCRIPTION MATURITY WTG AVG WTG AVG NO OF TRADED LAST TRADED DATE PRICE YLD% TRADES VALUE* PRICE YIELD ============ ============ ======== ======= ======= ====== ===== =============== INE053F14088 INDIAN RAILWAY FIN 60D 12-Dec-17 99.9833 6.0892 5 375 99.9833